application) This research is to improve quantification of radiation absorbed dose to tumors in patients following administration of therapeutic amounts of radiopharmaceuticals using single-photon emission computed tomography (SPECT). The macro-dosimetric result is to be correlated with local response to therapy and a tracer-imaging protocol will be developed. Non-Hodgkins' B-cell lymphoma patients are being successfully treated by I-131 labeled monoclonal antibodies. A dose-monitoring protocol has improved on standard procedure and is producing more plausible dose-response curves. The investigators will increase the data-processing efficiency in order to apply it to more patients. They will also further improve SPECT quantitative accuracy as follows: a) To determine when energy extrapolation of x-ray computed tomography (CT) values for SPECT attenuation correction needs to be replaced by radionuclide transmission scanning, they will compare the two methods for an anthropomorphic phantom. b) To extend accurate correction for Compton scattering they will characterize by Monte-Carlo simulation where the dual-energy-window method begins to fail. They will employ spectral fitting, using a special computer to acquire local energy spectra. c) To obtain accurate results from CT regions of interest (ROIs) superimposed on SPECT slices, they will develop a region-growing computer program that accounts for poorer SPECT resolution and slight misalignments. They will also improve accuracy of the dosimetry by investigating (1) the intra-observer variability of the CT tumor volume, (2) the shape of the conjugate-view time-activity curve (CV TAC), and (3) the behavior of % uptake as administered activity is increased. To develop dosimetric estimation from SPECT tracer studies, they will employ constrained, least-squares fitting of the projection data to compensate for poor counting statistics. Finally, to gain fuller information from human-tumor studies in animals, a miniature, implantable beta spectrometer will be developed, calibrated, and tested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA038790-06
Application #
3177082
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1985-09-01
Project End
1995-06-30
Budget Start
1990-09-01
Budget End
1991-06-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Koral, Kenneth F; Dewaraja, Yuni; Li, Jia et al. (2003) Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. J Nucl Med 44:457-64
Koral, Kenneth F; Francis, Isaac R; Kroll, Stewart et al. (2002) Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method. Cancer 94:1258-63
Dewaraja, Y K; Ljungberg, M; Koral, K F (2000) Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study. J Nucl Med 41:1760-7
Koral, K F; Dewaraja, Y; Li, J et al. (2000) Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma. J Nucl Med 41:1579-86
Koral, K F; Dewaraja, Y; Clarke, L A et al. (2000) Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary report. Cancer Biother Radiopharm 15:347-55
Dewaraja, Y K; Ljungberg, M; Koral, K F (2000) Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging. J Nucl Med 41:123-30
Koral, K F; Li, J; Dewaraja, Y et al. (1999) I-131 anti-B1 therapy/tracer uptake ratio using a new procedure for fusion of tracer images to computed tomography images. Clin Cancer Res 5:3004s-3009s
Koral, K F; Lin, S; Fessler, J A et al. (1997) Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma. Cancer 80:2538-44
Luo, J Q; Koral, K F; Ljungberg, M et al. (1995) A Monte Carlo investigation of dual-energy-window scatter correction for volume-of-interest quantification in 99Tcm SPECT. Phys Med Biol 40:181-99
Koral, K F; Zasadny, K R; Kessler, M L et al. (1994) CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med 35:1714-20

Showing the most recent 10 out of 21 publications